Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Endocrinologists weigh future of obesity management
• ACP recommends not using intensive insulin therapy in hospitalized patients
• Additional 5 years of life found as an unexpected benefit of bisphosphonate use
• Adherence to glucocorticoid treatment guidelines improved, but risk for adrenal failure remains
• Adults may benefit from routine screening for hypothyroidism
• Age at onset of puberty predicts adult osteoporosis risk
• BMI, mortality linked in Asians
• CDC findings highlight continued need for better control of hypertension, LDL
• CDC survey shows half of office-based physicians using EMRs
• Coping strategies less effective in patients with pituitary adenomas
• Diabetic retinopathy screening by endocrinologist using digital fundus camera is safe, secure
• Dietary guidelines for Americans updated
• EPA to develop standard for perchlorate
• Experts issue guidance for diagnosing, treating hyperprolactinemia
• FDA approves Lap-Band for less obese adults
• FDA approves synthetic form of progesterone
• FDA: Insulin glargine, cancer risk still under review
• Genetically low GH activity linked to diabetes, cancer protection in unique population
• Guidelines updated for managing children with type 1 diabetes at school
• Home glucose monitoring systems fall short in hospital settings
• Hypertension may be caused by mutation in adrenal gland
• Meta-analysis: No increased heart risk with progestogen contraceptive
• Obese patients with diabetes may fare better with gastric bypass surgery vs. other procedures
• Teriparatide improved outcomes of periodontal surgery
• Two-year bone density screening may be unnecessary for women with normal T-scores
• Updated guidelines for CVD prevention in women encompass clinical practice findings
• The times are changing Richard O. Dolinar, MD
• A rollercoaster of emotions Ronald Tamler, MD, PhD, MBA; Rifka Schulman-Rosenbaum, MD
• Diabetes educators and the patient-centered medical home Donna Tomky, MSN, RN, C-NP, CDE
• Incretin secretion, action in the natural history of type 2 diabetes Irfan Vardarli, MD; Juris J. Meier, MD; Michael A. Nauck, MD, PhD
• The mercury sphygmomanometer: End of an era?
• Pituitary mass with vision loss is not always a pituitary adenoma Philip E. Knapp, MD; Pornpoj Pramyothin, MD
• Age-specific anti-Müllerian hormone values determined for US women of reproductive age who present to fertility centers
• Androgen deprivation therapy for prostate cancer linked to bone decay
• Antioxidants may boost fertility in men
• Basal bolus insulin bested SSI therapy in surgery patients with type 2 diabetes
• Closed-loop insulin delivery shows promise in pregnant women with type 1 diabetes
• Enterovirus infection linked to type 1 diabetes
• Fat linked to DNA methylation may help explain obesity-related diseases
• Genetic mutations may increase susceptibility to hypothalamic amenorrhea
• Increased intraocular pressure, cataract risk found with anterior peribulbar triamcinolone
• Older people with metabolic syndrome more likely to experience cognitive decline
• Pre-existing diabetes associated with all-cause mortality in breast cancer
• Total thyroidectomy safe, effective for Graves’ disease
• Weight maintenance achieved with high-protein, low-glycemic-index diet
• ACTH testing still best option in identifying risk for adrenal insufficiency
• Clitoromegaly: A rare clinical finding in extremely premature infants
• Corneal confocal microscopy may aid in detecting diabetic neuropathy
• Imaging of the pituitary gland an important tool in pediatric endocrinology
• Newborn screening beneficial, but not always cost-saving